Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitioN with prasugrel (TRITON)–Thrombolysis in Myocardial Infarction (TIMI) 38 Substudy

Background Prasugrel led to a significant reduction in ischemic cardiovascular events among patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI) with stent implantation compared to clopidogrel. Whether this benefit extends to patients undergoing PCI without...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	The American heart journal 2009-09, Vol.158 (3), p.e21-e26
Hauptverfasser:	Pride, Yuri B., MD, Wiviott, Stephen D., MD, Buros, Jacqueline L., BS, Zorkun, Cafer, MD, Tariq, M. Umer, BS, Antman, Elliott M., MD, Braunwald, Eugene, MD, Gibson, C. Michael, MS, MD
Format:	Artikel
Sprache:	eng
Schlagworte:	Acute Coronary Syndrome - drug therapy Acute Coronary Syndrome - therapy Acute coronary syndromes Aged Angioplasty, Balloon, Coronary Aspirin - therapeutic use Cardiovascular Drug therapy Female Heart attacks Humans Male Middle Aged Piperazines - therapeutic use Platelet Aggregation Inhibitors - therapeutic use Prasugrel Hydrochloride Stents Thiophenes - therapeutic use Ticlopidine - analogs & derivatives Ticlopidine - therapeutic use
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!